ConductScience.org, home

Paper36944680

Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.

Chiasson-MacKenzie C and 7 others. Nat Commun, 2023. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Papers, record 36944680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944680

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.
PubMed
Journal
Nat Commun
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
2.95
iCite
Revised in PubMed
2024-08-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chiasson-MacKenzie CChristinehttps://orcid.org/0000-0002-4820-9765
2Vitte JJeremiehttps://orcid.org/0000-0002-2567-7988
3Liu CHChing-Hui
4Wright EAEmily A
5Flynn EAElizabeth A
6Stott SLShannon L
7Giovannini MMarcohttps://orcid.org/0000-0001-5183-8506
8McClatchey AIAndrea Ihttps://orcid.org/0000-0002-6150-3619

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neurofibromatosis 2Major topic
NeurilemmomaMajor topic
Animals
Mice
Humans
Neurofibromin 2
Mutation
Schwann Cells
Genes, Tumor Suppressor

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA226871NCI NIH HHSUnited StatesR01CA226871PubMedNIH RePORTER
S10 OD025017NIH HHSUnited StatesS10OD025017PubMed and NIHNIH RePORTER

Download CSV of grants

References83

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127273766YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.Nat Neurosci2016https://conductscience.org/library/papers/27273766PubMed
222426462Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types.Mol Cancer Res2012https://conductscience.org/library/papers/22426462PubMed
325113746A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.Hum Mol Genet2015https://conductscience.org/library/papers/25113746PubMed
422516196Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling.Dev Cell2012https://conductscience.org/library/papers/22516196PubMed
524687281Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system.J Cell Biol2014https://conductscience.org/library/papers/24687281PubMed
635580586mTOR substrate phosphorylation in growth control.Cell2022https://conductscience.org/library/papers/35580586PubMed
727655473Neurofibromatosis Type 2.J Child Neurol2017https://conductscience.org/library/papers/27655473PubMed
823249734Merlin/ERM proteins establish cortical asymmetry and centrosome position.Genes Dev2012https://conductscience.org/library/papers/23249734PubMed
930143526Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface.Genes Dev2018https://conductscience.org/library/papers/30143526PubMed
1016341207The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.Nat Cell Biol2006https://conductscience.org/library/papers/16341207PubMed
1117893219Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns.AJNR Am J Neuroradiol2007https://conductscience.org/library/papers/17893219PubMed
1232404937Chemotaxing neutrophils enter alternate branches at capillary bifurcations.Nat Commun2020https://conductscience.org/library/papers/32404937PubMed
1321182951Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.Mol Cell Neurosci2011https://conductscience.org/library/papers/21182951PubMed
1432547370Metabolic Interaction Between Schwann Cells and Axons Under Physiological and Disease Conditions.Front Cell Neurosci2020https://conductscience.org/library/papers/32547370PubMed
1527672367Macropinocytosis Exploitation by Cancers and Cancer Therapeutics.Front Physiol2016https://conductscience.org/library/papers/27672367PubMed
1625706233A molecular mechanotransduction pathway regulates collective migration of epithelial cells.Nat Cell Biol2015https://conductscience.org/library/papers/25706233PubMed
1720511180ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.Neuro Oncol2010https://conductscience.org/library/papers/20511180PubMed
1820832498Nrg1/ErbB signaling networks in Schwann cell development and myelination.Semin Cell Dev Biol2010https://conductscience.org/library/papers/20832498PubMed
1924311643Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas.Neuro Oncol2014https://conductscience.org/library/papers/24311643PubMed
2026928656Extracellular vesicles for drug delivery.Adv Drug Deliv Rev2016https://conductscience.org/library/papers/26928656PubMed

See all 83 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42764387Advancing neurofibromatosis research: a comparative review of animal models and their utility in dissecting the tumor microenvironment.Lab Anim Res2026https://conductscience.org/library/papers/42764387PubMed
42662719NF2 lacking exon 11 induced by antisense gene therapy is able to partially recover merlin deficiency in NF2-SWN iPSC-derived spheroid model.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42662719PubMed
42143176Vestibular schwannoma: genetic and epigenetic mechanisms, hearing loss, and emerging therapies.J Neurooncol2026https://conductscience.org/library/papers/42143176PubMed
42035704Data-driven thresholds for standardized classification of severe Alzheimer's disease neuropathology using digital neuropathology.Brain Pathol2026https://conductscience.org/library/papers/42035704PubMed
42034799Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.Acta Neuropathol2026https://conductscience.org/library/papers/42034799PubMed
41988151Endoscopic-assisted low-temperature plasma resection of tongue root schwannoma via oral approach: a case report and literature review.Front Pediatr2026https://conductscience.org/library/papers/41988151PubMed
41929036Quantitative imaging of schwannoma captures heterogeneity and accelerates preclinical testing, revealing distinct impacts of targeted therapies.bioRxiv2026https://conductscience.org/library/papers/41929036PubMed
41898726Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis.Int J Mol Sci2026https://conductscience.org/library/papers/41898726PubMed
41461563In vivo screen reveals specific roles of Hippo pathway components in development and regeneration.Life Sci Alliance2026https://conductscience.org/library/papers/41461563PubMed
41293003Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.bioRxiv2025https://conductscience.org/library/papers/41293003PubMed
41001135Schwann cells in the inner ear: development, disease, and regeneration.Front Cell Neurosci2025https://conductscience.org/library/papers/41001135PubMed
40940747Pathologic and Therapeutic Schwann Cells.Cells2025https://conductscience.org/library/papers/40940747PubMed
40895102Investigating cochlear cellular dynamics in neurofibromatosis type 2-associated schwannomatosis: a histopathological study.Front Neurol2025https://conductscience.org/library/papers/40895102PubMed
40746735iPSC-based merlin-deficient Schwann cell-like spheroids as an in vitro system for studying NF2 pathogenesis.Genes Dis2025https://conductscience.org/library/papers/40746735PubMed
40343504Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities.Acta Neuropathol2025https://conductscience.org/library/papers/40343504PubMed
39941762Genetic Alterations in Patients with NF2-Related Schwannomatosis and Sporadic Vestibular Schwannomas.Cancers (Basel)2025https://conductscience.org/library/papers/39941762PubMed
39910685Current molecular understanding of central nervous system schwannomas.Acta Neuropathol Commun2025https://conductscience.org/library/papers/39910685PubMed
38372904Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.J Neurooncol2024https://conductscience.org/library/papers/38372904PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36944680

GET https://conductscience.org/api/papers/v1/36944680/references?page=2